0
Kalaris Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−170
FY22:
−171
FY23:
−200
FY24:
−51.7
FY25:
−46.2
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−43.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−171
FY22:
−169
FY23:
−191
FY24:
−69.2
FY25:
−43.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−172
FY22:
−169
FY23:
−190
FY24:
−69.2
FY25:
−43.4
All amounts in millions USD